AGU
CMD

Alpine Group USVI’s Cantel Medical Corporation CMD Stock Holding History

Alpine Group USVI’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$377K Buy
+4,843
New +$364K 0.12% 73

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Alpine Group USVI's CMD Position: Q2 2017 in Review

Alpine Group USVI opened a new position in Cantel Medical Corporation (CMD) in Q2 2017: 4,843 shares worth $377K. The stake represents 0.12% of the portfolio and ranks #73 among its holdings.

214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • Alpine Group USVI held 4,843 shares of Cantel Medical Corporation worth $377K as of Q2 2017.
  • Cantel Medical Corporation was a new Alpine Group USVI position in Q2 2017.
  • Cantel Medical Corporation made up 0.12% of Alpine Group USVI's portfolio in Q2 2017, its #73 holding.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on Alpine Group USVI's 13F filing for Q2 2017, filed 14 Aug 2017.